AL-15469A ophthalmic suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AL-15469A ophthalmic suspension, covering 2011-12-01 to 2011-12-01. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis [Phase 2]